Why Are ImpediMed Shares Up 14.44% Today?

By ,

At the time of writing, shares of ImpediMed Limited [ASX:IPD] are up by 14.44% from this morning’s open, trading at 51 cents in today’s market.

ImpediMed is a global company founded in Brisbane, Australia, with US and European operations. It is a world leader in the design and manufacturing of advanced medical products which use bioimpedance spectroscopy technology (BIS).

What caused ImpediMed shares to rise?

Two of ImpediMed’s products featured prominently at The Australasian Lymphology Association (ALA) conference held from May 17–19 this year may have contributed to their share value growth. After record attendance at that conference, things have only continued to improve for ImpediMed.

Leonie Naumann, President of the Australasian Lymphology Association, said:

We are delighted to report that the 12th ALA conference, like the association has enjoyed very strong growth over the last four years. The ALA enjoys increasingly strong support from industry, including ImpediMed one of the ALA’s industry Partners.

The two key ImpediMed products featured were the ‘L-Dex’ and ‘Sozo’. Both medical diagnostic devices that allow aspects of a patient’s body to be scanned and monitored non-invasively.

What next for ImpediMed?

With higher cash flows forecasted for the company, and profit expected to continue growing over the next couple of years, the future of ImpediMed seems bright.


Ryan Clarkson-Ledward,
For Money Morning

PS: Looking for ASX-listed stocks with the potential to explode upward in price? Money Morning editor Sam Volkering argues that the greatest gains can be made in the small, obscure stocks that most investors have never heard of…yet. He’s authored a free report looking at three stocks that could have the potential to go from unknown to household names. Find out more in this free report ‘Top Three Aussie Stocks to Own in 2018’.

About Ryan Clarkson-Ledward

Ryan Clarkson-Ledward is an Editor at Money Morning.

Ryan holds degrees in both communication and international business. He helps bring Money Morning readers the latest market updates, both locally and abroad. Ryan tackles all the issues investors need to know about that the mainstream media neglects.

Ryan is also the Editor…

Vulcan Energy Shares Surge on Stellantis Equity Stake

Lithium developer Vulcan Energy [ASX:VUL] rose as much as 30% on Friday after conglomerate automaker Stellantis made a $76 million equity investment in the stock.

Lithium Price Disconnect: Why the Mainstream Has Got It Wrong

It was another rough day of trading for commodities on Thursday. But of all the sectors hit, lithium stocks once again bore the brunt of the sell-off.

PayGroup Shares Rise 150% on Takeover Bid

Human capital management and payroll firm PayGroup [ASX:PYG] soared on Thursday after global payroll platform Deel made a $119 million offer.

Pilbara Minerals Pre-Auction Bid Reflects ‘Strong Demand’

Australian lithium producer Pilbara Minerals [ASX:PLS] secured a pre-auction bid of over US$7,000/dry metric tonne.

Humm Shares Fall on Director Exodus

Humm Group [ASX:HUM] shares fell on Wednesday as the fallout of the scrapped Latitude deal triggers a director exodus. The saga of Humm’s failed sale of its consumer finance segment to Latitude rolls on. Humm’s majority directors are on their way out. Two directors have resigned effectively immediately, while three others — including Humm chair … Read More

Lake Resources (ASX:LKE) Shares Fall 45% in a Week

Lake Resources (ASX:LKE) shares continue to plummet as investors remain uncertain about the significance of the departure of LKE’s managing director.